M&A Healthcare Advisors Advises Innovo Detox on Sale to R&S Holdings, Inc.

Markets PR Newswire By PR Newswire 12 Oct 2026 20:58 1 min read
M&A Healthcare Advisors Advises Innovo Detox on Sale to R&S Holdings, Inc.

LOS ANGELES, Oct. 12, 2026 /PRNewswire/ -- M&A Healthcare Advisors (MAHA), a FINRA-licensed investment bank focused on the healthcare industry, is pleased to announce the sale of Innovo Detox (Innovo), a Pennsylvania-based provider of substance use disorder (SUD) treatment and drug and...

Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.